Maravai Lifesciences Holdings (MRVI) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -76.51% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -303.06% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 18.06% |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 75.42% |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 67.94% |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn | 94.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.82% |
| Dec 31, 2025 | -167.95% |
| Sep 30, 2025 | 50.65% |
| Jun 30, 2025 | -763.92% |
| Mar 31, 2025 | -317.79% |
| Dec 31, 2024 | -620.98% |
| Sep 30, 2024 | -816.89% |
| Jun 30, 2024 | 31.94% |
| Mar 31, 2024 | -911.03% |
| Dec 31, 2023 | -104.33% |
| Sep 30, 2023 | -103.55% |
| Jun 30, 2023 | -104.06% |
| Mar 31, 2023 | -99.66% |
| Dec 31, 2022 | -51.24% |
| Sep 30, 2022 | 84.37% |
| Jun 30, 2022 | 103.03% |
| Mar 31, 2022 | 444.55% |
| Dec 31, 2021 | 520.27% |
| Sep 30, 2021 | 213.49% |
| Jun 30, 2021 | 1,744.85% |